CJC-1295 (No DAC) / Mod GRF (1-29)

TheraTide USA

$60.99 - $120.99
CJC-1295 (No DAC) / Mod GRF (1-29)
Availability:
In Stock
Adding to cart… The item has been added

Lyophilized Peptides: These peptides are freeze-dried, a process that not only extends shelf life but also preserves the purity and integrity of the peptides during storage.

Non-Lyophilized Peptides: Offered as a dry powder, these peptides, while not as extensively processed as lyophilized peptides, still maintain a high level of purity. Their stability, though not as enhanced as in lyophilized form, is sufficient for maintaining quality under proper storage conditions.

98.5% vs. 99% Purity: Both grades go through our lyophilization process in our US-based facility and are tested for quality at a third party lab. While the 99%+ purity grade is our highest reference grade product line, the 98.5% purity variants still exceed US pharmaceutical standards.

Product Overview

CJC-1295 No DAC (Modified GRF 1-29) is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). It consists of 29 amino acids and is designed to stimulate the pituitary gland to increase growth hormone (GH) secretion. Unlike its counterpart with DAC (Drug Affinity Complex), this version has a shorter half-life, making it more suitable for research focused on pulsatile hormone release.

  • Molecular Formula: C152H252N44O42
  • Molecular Weight: 3367.9 g/mol
  • Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
  • Available Sizes: 5mg, 10mg
  • Purity Grades: Lyophilized 99%+, Lyophilized 98.5%+, Non-Lyophilized 98.5%+
  • Form: Lyophilized or Non-Lyophilized Powder

Our CJC-1295 No DAC products undergo rigorous third-party testing to ensure the highest purity and quality standards. Certificates of Analysis (COA) are available upon request and include detailed information on:

  • Purity Levels
  • Peptide Sequence Verification
  • Contaminant Screening
  • Batch Numbers
  • Testing Dates

To request a COA for your specific batch, please contact our customer support team with your order details.

CJC-1295 No DAC has been extensively studied for its effects on growth hormone release and potential therapeutic applications. Key research findings include:

  • Growth Hormone Release: Research has shown that CJC-1295 effectively stimulates growth hormone release by activating the growth hormone-releasing factor (GRF) receptor on the anterior pituitary gland. In studies conducted on rats, CJC-1295 demonstrated a significant increase in GH levels, with a 4-fold increase in the area under the curve over a 2-hour period compared to other GRF analogs. [Source]
  • Enhanced Stability: Modified GRF (1-29) is a synthetic modification of growth hormone releasing factor (GRF) with D-Ala, Gln, Ala, and Leu substitutions at positions 2, 8, 15, and 27 respectively. These substitutions create a much more stable peptide with the substitution at position 2 to prevent DPP-IV cleavage, position 8 to reduce asparagine rearrangement or amide hydrolysis to aspartic acid, position 15 to enhance bioactivity, and position 27 to prevent methionine oxidation. [Source]
  • Physiological Effects: Studies have explored its potential for muscle growth, improving metabolism, and supporting recovery processes. [Source]

What is CJC-1295 No DAC?

CJC-1295 No DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to stimulate the pituitary gland to increase growth hormone secretion. It consists of 29 amino acids and is modified to enhance stability and effectiveness.

How does CJC-1295 No DAC differ from CJC-1295 with DAC?

The primary difference lies in the half-life. CJC-1295 with DAC includes a Drug Affinity Complex that extends its half-life, leading to prolonged hormone release. In contrast, CJC-1295 No DAC has a shorter half-life, making it more suitable for research focused on pulsatile hormone release.

What are the potential benefits of CJC-1295 No DAC?

Potential benefits observed in research settings include increased growth hormone release, improved muscle growth, enhanced metabolism, and support for recovery processes.

Is CJC-1295 No DAC safe?

CJC-1295 No DAC is intended for research purposes only. Safety profiles are based on clinical studies, and it should not be used for human consumption.

Do I need a prescription for CJC-1295 No DAC?

No, CJC-1295 No DAC is sold for research purposes only and is not intended for human use. A prescription is not required for purchase.

This product is sold as a pure compound for research purposes only and is not intended for use as a dietary supplement. Please refer to our terms and conditions prior to purchase.

Safety Information: Keep this product out of the reach of children. This material has limited research available and may result in adverse effects if improperly handled or consumed. This product is not a dietary supplement but a pure substance, sold as a raw material. We attest exclusively to the quality, purity, and description of the materials we provide. This product is for use and handling only by persons with the knowledge and equipment to safely handle this material.

All products offered by TheraTide USA are strictly intended for research and development purposes only.

None of the statements on this website have been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.

TheraTide USA is a research chemical supplier. We are not a compounding pharmacy or a chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act.